Early access program for doxorubicin liposomal [ThermoDox] in patients with recurrent chest wall breast cancer
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 10 Aug 2015
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer; Liver cancer
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 10 Aug 2015 Status changed from not yet recruiting to recruiting according to a Celsion Corporation media release.
- 10 Aug 2015 According to a Celsion Corporation media release, this EAP study was expanded to include patients with primary liver cancer and liver cancer metastases.
- 06 Aug 2015 New trial record